Advertisement
U.S. markets closed
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • Dow 30

    39,807.37
    +47.29 (+0.12%)
     
  • Nasdaq

    16,379.46
    -20.06 (-0.12%)
     
  • Russell 2000

    2,124.55
    +10.20 (+0.48%)
     
  • Crude Oil

    83.11
    -0.06 (-0.07%)
     
  • Gold

    2,254.80
    +16.40 (+0.73%)
     
  • Silver

    25.10
    +0.18 (+0.74%)
     
  • EUR/USD

    1.0781
    -0.0013 (-0.12%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • dólar/libra

    1.2622
    -0.0000 (-0.00%)
     
  • USD/JPY

    151.2800
    -0.0920 (-0.06%)
     
  • Bitcoin USD

    70,407.12
    +660.12 (+0.95%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,340.04
    +171.97 (+0.43%)
     

David Einhorn Axes GM, Buys Change Healthcare in the 1st Quarter

David Einhorn (Trades, Portfolio), chairman of Greenlight Capital Re Ltd.'s (NASDAQ:GLRE) board of directors, disclosed last week that his hedge fund eliminated its stake in General Motors Co. (NYSE:GM) during the first quarter. The fund established 11 new positions with the proceeds, including top buys in Change Healthcare Inc. (NASDAQ:CHNG), Crown Holdings Inc. (NYSE:CCK) and Centene Corp. (NYSE:CNC).


f9adecaa728e3f983247757e56dc822c.png
f9adecaa728e3f983247757e56dc822c.png

The fund said in its quarterly letter that Greenlight returned -21.50% during the three months ended March 31, underperforming the S&P 500 Index's return of -19.60% as the coronavirus pandemic crippled the U.S. economy. Greenlight's letter said that on balance, the decision in the U.S. stems from the aim to decelerate the spread of Covid-19 "at the expense of the economy," yet "socialize as much of the cost as possible."

As of the quarter end, Greenlight's $702 million equity portfolio contains 23 stocks, with a turnover ratio of 24%. The top three sectors in terms of weight are consumer cyclical, financial services and health care, representing 32.64%, 17.10% and 12.33% of the equity portfolio.

6af320e161e93c15240d3b92c594822b.png
6af320e161e93c15240d3b92c594822b.png

Sold out: General Motors

Greenlight sold its 6,154,702 shares of GM, freeing up 16.71% of its equity portfolio. The shares averaged $30.77 during the first quarter; Greenlight gained approximately 10% on the stock according to GuruFocus estimates.

f2b7dc4c367df98013521541afc3f9da.png
f2b7dc4c367df98013521541afc3f9da.png

Greenlight said in its quarterly letter that the long positions, which are pro-cyclical and more leveraged than the short positions, tumbled "almost twice as much as the market" during the quarter. While Einhorn expected a rebound in GM's earnings and cash flow for 2020, the annual guidance missed Greenlight's expectations. Einhorn's hopes that 2020 was the year that GM rebounded were dashed during the company's analyst day.

87cacf98bcbde3a2e2e341dbc0907701.png
87cacf98bcbde3a2e2e341dbc0907701.png

GuruFocus ranks the Detroit-based auto manufacturer's financial strength 4 out of 10 on several warning signs, which include a weak Altman Z-score of 0.91 and a debt-to-equity ratio that underperforms 95% of global competitors. The website further warns that long-term debt has increased over the past three years while revenues have declined over the past year.

8f5b090328df590fd899b9ed106e13c8.png
8f5b090328df590fd899b9ed106e13c8.png

Warren Buffett (Trades, Portfolio)'s Berkshire Hathaway Inc. (NYSE:BRK.A)(NYSE:BRK.B) owns 74.681 million shares of GM as of March, essentially unchanged from the 75 million shares as of December 2019.

13241fb58406b28a50640af9b474e5c0.png
13241fb58406b28a50640af9b474e5c0.png

New buy: Change Healthcare

Greenlight purchased 5,294,005 shares of Change Healthcare, dedicating 7.53% of the equity portfolio to the stake. Shares averaged $14.09 during the first quarter.

1fdac120bf5edfcaa7e83d0347a0420c.png
1fdac120bf5edfcaa7e83d0347a0420c.png

The Nashville, Tennessee-based company went public around June 27, 2019. The health care technology company offers a suite of software, analytics, technology-enabled services and network solutions that drive results in the workflows of health care system payers and providers.

Greenlight said in its quarterly letter that following one-time events like "planned contract eliminations, the rollout of a new imaging platform and the shift to ASC 606 accounting standards," the fund sees solid growth in the coming years "with the resumption of elective synergies."

Crown Holdings

Greenlight purchased 213,500 shares of Crown Holdings, giving the position 1.77% weight in the equity portfolio. Shares averaged $69.87 during the first quarter.

b08af5d39a66826f6bd49ee789ebc1ab.png
b08af5d39a66826f6bd49ee789ebc1ab.png

The Yardley, Pennsylvania-based company manufactures beverage cans, metal food cans and aerosol cans. GuruFocus ranks the company's financial strength 3 out of 10 on the back of debt ratios underperforming over 78% of global competitors: Crown Holdings' long-term debt has increased by approximately $3.6 billion over the past three years, a warning sign of high leverage.

c05eb4b8703e5ea998cbf339ef52339a.png
c05eb4b8703e5ea998cbf339ef52339a.png

Despite low financial strength, Crown Holdings' profitability ranks 9 out of 10 on the back of a GuruFocus business predictability rank of five stars and a return on equity that outperforms over 98% of global packaging companies.

0aa25e9199223ab7e1dbfc468821109c.png
0aa25e9199223ab7e1dbfc468821109c.png

Centene

Greenlight purchased 204,700 shares of Centene, giving the holding 1.73% weight in the equity portfolio. Shares averaged $60.83 during the first quarter.

22ec0b0d386dfe2e087bd3ec9f14cc7f.png
22ec0b0d386dfe2e087bd3ec9f14cc7f.png

According to GuruFocus, the St. Louis-based health care plans company has a weak Piotroski F-score of 2 and debt ratios underperforming over 60% of global competitors, suggesting suboptimal business operations.

44632aeb29c9b85e55a99c0d74e8fbfc.png
44632aeb29c9b85e55a99c0d74e8fbfc.png

Disclosure: No positions.

Read more here:

  • Top 5 Buys of Ray Dalio's Bridgewater in the 1st Quarter

  • Seth Klarman's Top 5 New Buys in the 1st Quarter

  • Prem Watsa's Top 5 Buys in the 1st Quarter



Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.

This article first appeared on GuruFocus.


Advertisement